Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine: a phase 2 randomised, placebo-controlled, parallel-group, dose-ranging study

Markus Färkkilä, Hans-Christoph Diener, Gilles Geraud, Miguel Lainez, Jean Schoenen, Nadja Harner, Alison Pilgrim, Uwe Reuter, COL MIG-202 Study Grp

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalLancet Neurology
Volume11
Issue number5
Pages (from-to)405-413
Number of pages9
ISSN1474-4422
DOIs
Publication statusPublished - 2012
MoE publication typeA1 Journal article-refereed

Fields of Science

  • PHARMACOLOGICAL PROFILE
  • GUINEA-PIG
  • LOCALIZATION
  • TRIPTANS
  • COL-144
  • ATTACKS
  • BRAIN
  • RAT
  • 3124 Neurology and psychiatry

Cite this